Hospital Compounding: More Than a Pharmacy Issue

Author(s):  Alexander Michael R, Combs Blinn E, Earl Matthew D, Howard Brad

Issue:  Sep/Oct 2026 - Volume 30, Number 5
View All Articles in Issue

Abstract:  Hospitals may procure finished pharmaceutical products from drug manufacturers and wholesalers. For a wide variety of patient care settings, however, clinicians may need to alter the standard dosage, dosage form, route of administration, or other features of a manufactured drug therapy. These changes to drug products, which involve interacting with the finished drug substance in a way that changes its final form prior to administration, typically implicate diverse state, federal, and accreditation body regulations on pharmaceutical compounding. Most health care providers are familiar with pharmaceutical compounding mainly through their interactions with pharmacies and outsourcing facilities. Because providers operate some distance from the activity of compounding and its associated regulatory burdens, they view compounding regulations primarily through the lens of business-to-business transactions. Because of their unique position as primary sites of care and medical administration, hospitals are more directly impacted by compounding regulations.

Related Keywords: USP, Joint Commission, Survey, Accreditation, Hospitals, Immediate-Use Compounding, Scope of Practice, Training, Competency Evaluations, Sterile Compounding, 503a, 503b, Conditions of Participation, Deemed Status, Compliance, Hospital Compliance, Hospital Compounding, Emergency Compounding, Compounding Pharmacy, Outsourcing Facility, Alexander Michael R, Combs Blinn E, Earl Matthew D, Howard Brad

Related Categories: SUPPORT, HOSPITAL PHARMACY, PROFESSIONAL ISSUES

Purchase this article for download in electronic PDF format from IJPC at for $75 at:
https://ijpc.com/Abstracts/Abstract.cfm?ABS=5573

Search the entire IJPC archive by keyword, topic, or issue at:
https://ijpc.com/Products